4//SEC Filing
Zdimal Kevin P 4
Accession 0000790051-24-000168
CIK 0000790051other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 7:16 PM ET
Size
31.5 KB
Accession
0000790051-24-000168
Insider Transaction Report
Form 4
Zdimal Kevin P
V.P. &Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-07-26$423.17/sh−4,195$1,775,198→ 35,641 total - Exercise/Conversion
Common Stock
2024-07-26$110.79/sh+3,175$351,758→ 38,816 total - Sale
Common Stock
2024-07-26$424.16/sh−3,175$1,346,708→ 35,641 total - Exercise/Conversion
Common Stock
2024-07-26$161.41/sh+4,881$787,842→ 40,522 total - Exercise/Conversion
Common Stock
2024-07-26$161.41/sh+2,344$378,345→ 37,985 total - Sale
Common Stock
2024-07-26$425.90/sh−2,344$998,310→ 35,641 total - Exercise/Conversion
Common Stock
2024-07-26$150.00/sh+3,331$499,650→ 38,972 total - Sale
Common Stock
2024-07-26$428.26/sh−10$4,283→ 35,641 total - Exercise/Conversion
Common Stock
2024-07-26$110.79/sh+4,195$464,764→ 39,836 total - Sale
Common Stock
2024-07-26$425.10/sh−4,881$2,074,913→ 35,641 total - Sale
Common Stock
2024-07-26$427.62/sh−3,534$1,511,209→ 35,641 total - Exercise/Conversion
Common Stock
2024-07-26$150.00/sh+10$1,500→ 35,651 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-07-26−7,370→ 0 totalExercise: $110.79Exp: 2029-02-04→ Common Stock (7,370 underlying) - Exercise/Conversion
Common Stock
2024-07-26−7,225→ 0 totalExercise: $161.41Exp: 2030-02-03→ Common Stock (7,225 underlying) - Sale
Common Stock
2024-07-26$426.38/sh−3,331$1,420,272→ 35,641 total - Exercise/Conversion
Common Stock
2024-07-26$150.00/sh+3,534$530,100→ 39,175 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-07-26−6,875→ 0 totalExercise: $150.00Exp: 2031-02-01→ Common Stock (6,875 underlying)
Footnotes (10)
- [F1]This transaction was executed in multiple trades at prices ranging from $422.66 to $423.65. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F10]The option vested in three equal annual installments beginning on February 2, 2022.
- [F2]This transaction was executed in multiple trades at prices ranging from $423.66 to $424.58. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F3]This transaction was executed in multiple trades at prices ranging from $424.58 to $425.52. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F4]This transaction was executed in multiple trades at prices ranging from $425.58 to $426.08. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F5]This transaction was executed in multiple trades at prices ranging from $426.08 to $426.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F6]This transaction was executed in multiple trades at prices ranging from $427.10 to $428.08. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F7]The option vested in three equal annual installments beginning on February 5, 2020.
- [F8]The transaction is the exercise of a derivative security.
- [F9]The option vested in three equal annual installments beginning on February 4, 2021.
Documents
Issuer
CARLISLE COMPANIES INC
CIK 0000790051
Entity typeother
Related Parties
1- filerCIK 0001492140
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 7:16 PM ET
- Size
- 31.5 KB